<qa>  What is the name of the clinically relevant symptoms that have been reported in the 4 weeks prior- Participant has had clinically relevant symptoms or a clinically significant illness in the 4 weeks prior to screening or enrollment in the blinded phase of the trial, other than epilepsy. 